Literature DB >> 24118383

Molecular investigation of menstrual tissue for the presence of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis collected by women with a history of infertility.

I Vassiliki Michou1, Pantelis Constantoulakis, Kostantinos Makarounis, Giorgos Georgoulias, Vassilis Kapetanios, Vassilis Tsilivakos.   

Abstract

AIM: At present, routine laboratory investigation of the infectious agents implicated in female genital infections is mainly based on culture/direct fluorescence antibody (DFA) (immunofluorescence antibody test) results of cervicovaginal secretions. In this study the use of the menstrual tissue is introduced for the molecular detection of pathogens which are implicated in female infertility.
MATERIAL AND METHODS: Cervicovaginal secretions and menstrual tissue samples of 87 women (mean age 34.07 ± 5.17) experiencing infertility problems were screened for Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis presence using polymerase chain reaction (PCR, light cycler-PCR). Cervicovaginal secretions were also tested by the culture/DFA technique. The results were compared using the binomial test.
RESULTS: In the overall study group, the prevalence of C. trachomatis was 25.3%, 18.3%, and 13.8%, the prevalence of U. urealyticum was 18.3%, 16.09% and 12.6% and the prevalence of M. hominis was 13.7%, 19.5% and 8.0% in the menstrual tissue, cervicovaginal secretions using PCR and cervicovaginal secretions culture/DFA, respectively. A statistically significant difference was revealed between the two methods for all three microbes and between menstrual tissue and cervicovaginal secretions PCR for chlamydia.
CONCLUSIONS: The use of menstrual tissue along with the PCR method seems to be an effective and thus novel alternative for the investigation of the infectious agents lying in the genital tract. One of the main advantages of this technique compared to cervicovaginal secretions is that it is non-invasive and the sample can be collected at home, thus allowing the early detection and treatment of a condition that can otherwise lead to serious consequences, such as tubal obstruction, pelvic inflammatory disease, ectopic pregnancy, spontaneous abortions and unexplained infertility.
© 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  Chlamydia trachomatis; Mycoplasma hominis; Ureaplasma urealyticum; infertility; menstrual tissue; sexually transmitted infection

Mesh:

Substances:

Year:  2013        PMID: 24118383     DOI: 10.1111/jog.12165

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  8 in total

1.  Development a rapid and accurate multiplex real time PCR method for the detection Chlamydia trachomatis and Mycoplasma hominis.

Authors:  Roya Safarkar; Jalil Fallah Mehrabadi; Zahra Noormohammadi; Reza Mirnejad
Journal:  J Clin Lab Anal       Date:  2017-02-26       Impact factor: 2.352

2.  Patients with cervical Ureaplasma Urealyticum and Chlamydia Trachomatis infection undergoing IVF/ICSI-ET: The need for new paradigm.

Authors:  Qing-Zhen Xie; Wang-Ming Xu; Qian-Rong Qi; Zeng-Li Luo; Lan Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

3.  Prevalence of Mycoplasma genitalium and Mycoplasma hominis in urogenital tract of Brazilian women.

Authors:  Guilherme Barreto Campos; Tássia Neves Lobão; Nathan Neves Selis; Aline Teixeira Amorim; Hellen Braga Martins; Maysa Santos Barbosa; Thiago Henrique Caldeira Oliveira; Djanilson Barbosa dos Santos; Tiana Baqueiro Figueiredo; Lucas Miranda Marques; Jorge Timenetsky
Journal:  BMC Infect Dis       Date:  2015-02-14       Impact factor: 3.090

4.  Attitudes about Sex Selection and Sex Preference in Iranian Couples Referred for Sex Selection Technology.

Authors:  Seyedeh Fatemeh Ahmadi; Mahdi Shirzad; Koorosh Kamali; Fahimeh Ranjbar; Zohreh Behjati-Ardakani; Mohammad Mehdi Akhondi
Journal:  J Reprod Infertil       Date:  2015 Jan-Mar

5.  Prevalence of Chlamydia trachomatis, Ureaplasma spp., Mycoplasma genitalium and Mycoplasma hominis among outpatients in central Greece: absence of tetracycline resistance gene tet(M) over a 4-year period study.

Authors:  A Ikonomidis; C Venetis; D Georgantzis; V Giaslakiotis; V Kolovos; K Efstathiou; M Moschou; Ε Κoutsiaris; M Panopoulou
Journal:  New Microbes New Infect       Date:  2015-11-14

6.  The Prevalence of Ureaplasma Urealyticum and Mycoplasma Hominis Infections in Infertile Patients in the Northeast Region of Romania.

Authors:  Bogdan Doroftei; Ovidiu-Dumitru Ilie; Theodora Armeanu; Emil Anton; Ioana Scripcariu; Radu Maftei
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

7.  Development of a RPA-CRISPR-Cas12a Assay for Rapid, Simple, and Sensitive Detection of Mycoplasma hominis.

Authors:  Jialing Chen; Yinger Huang; Bin Xiao; Hao Deng; Kunxiang Gong; Kun Li; Linhai Li; Wenbo Hao
Journal:  Front Microbiol       Date:  2022-04-08       Impact factor: 6.064

8.  The Relationship between Chlamydia trachomatis Genital Infection and Spontaneous Abortion.

Authors:  Amjad Ahmadi; Mazaher Khodabandehloo; Rashid Ramazanzadeh; Fariba Farhadifar; Daem Roshani; Ebrahim Ghaderi; Niloofar Farhangi
Journal:  J Reprod Infertil       Date:  2016 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.